Merck Serono
Merck makes big changes at the top
October 1, 2013Medical Communications, Sales and Marketing Merck, Merck Serono
Merck has reshuffled its leadership as Belén Garijo is appointed to be its new president and chief executive of Merck …
Roche cancer treatment shows promise
September 30, 2013Sales and Marketing MPDL3280A, Merck Serono, NSCLC, Roche
An early-stage oncology treatment has shown encouraging results in smokers with lung cancer, Roche has said in a presentation at …
Merck Serono won’t give up on cancer vaccine
September 26, 2013Sales and Marketing Merck, Merck Serono, Stimuvax
Merck Serono’s once failed lung cancer vaccine treatment Stimuvax has been given a second chance as the German firm begins …
Merck Serono sets up cancer platform
July 3, 2013Research and Development, Sales and Marketing Cancer, Cladribine, Merck Serono, kgaa
Merck Serono is attempting to speed up R&D on products which stimulate the immune system to fight cancer by establishing …
Merck Serono censured over calls
June 25, 2013Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA
A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …
Merck signs lupus research deal
January 30, 2013Research and Development, Sales and Marketing Feinstein, Merck Serono, SLE
Merck Serono and the Feinstein Institute for Medical Research in New York are to collaborate on antibodies to treat systemic …
Merck Serono has redeployed a fifth of axed Swiss staff
October 2, 2012Manufacturing and Production Geneva, Merck Serono
Merck Serono says it has redeployed 260 of 1,250 staff affected by the closure and downsizing of sites in Switzerland …
Merck Serono says dispute over Geneva closure is resolved
August 10, 2012Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts
Merck Serono says it has reached agreement with groups representing workers affected by the closure and downsizing of sites in …
Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops
July 30, 2012Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss
A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …
Erbitux fails in gastric cancer trial
July 6, 2012Research and Development, Sales and Marketing Erbitux, Merck Serono, Roche, failure, gastric cancer
Merck’s Erbitux has failed to increase survival in patients with gastric cancer, representing a blow to the firm’s ambition to …
New head at the European Medicines Agency
July 4, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Merck Serono, Stallergenes
Merck Serono’s Enrica Alteri has been appointed by The European Medicines Agency as its new head of Safety and Efficacy …
Quintiles offers lifeline to Merck Serono employees
June 28, 2012Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts, manufacturing
Quintiles has said it will make at least 100 job offers within the next three months to workers set to …
Merck Serono tweaks Swiss restructuring plans
June 20, 2012Manufacturing and Production, Sales and Marketing Merck Serono, cuts, restructuring
Merck KGaA has finalised the restructuring plans at Swiss drugs unit Merck Serono, confirming that it intends to close its …
Merck Serono staff may strike over Geneva HQ closure
June 6, 2012Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D
Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …
Merck KGaA’s colon cancer drug fails trial
May 16, 2012Research and Development, Sales and Marketing Erbitux, Merck KGaA, Merck Serono, colon cancer
Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
